Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Induction Therapy-Docetaxel, Cisplatin and Fluorouracil in Untreated Advanced Squamous Cell or Undifferentiated Carcinoma of the Paranasal Sinuses
This study is currently recruiting participants.
Verified April 2013
by M.D. Anderson Cancer Center
Study NCT00707473 Information provided by M.D. Anderson Cancer Center
First Received on June 26, 2008. Last Updated on April 30, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Paranasal Sinus Neoplasms
Squamous Cell Carcinoma
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Squamous Cell
Neoplasms
More general conditions related to this trial
Head and Neck Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Nose Diseases
Nose Neoplasms
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Paranasal Sinus Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Interventions listed in this trial
Docetaxel
5-Fluorouracil
Cisplatin
Additional drug interventions recognized in this trial
Fluorouracil
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
Sanofi
Back to top of Main Content